Explore All 718 Buyout (LBO, MBO, MBI) Retail Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 19, 2019 |
| Target | You Garden |
| Sector | Retail |
| Buyer(s) | Kester Capital |
| Deal Type | Buyout (LBO, MBO, MBI) |
FILTER BY
Kester Capital is a private equity firm focused on middle-market company investments in the UK. The Firm looks to invest a minimum of £15 million in businesses valued up to £100 million. Kester Capital was originally established in 2007 as Greenhill Capital Partners Europe, the European private equity arm of Greenhill & Co Inc. Kester Capital is based in London.
| Deal Context for Buyer | # |
|---|---|
| Overall | 9 of 18 |
| Sector: Retail | 2 of 2 |
| Type: Buyout (LBO, MBO, MBI) | 8 of 12 |
| Country: United Kingdom | 6 of 13 |
| Year: 2019 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-05-01 |
Jollyes
Waltham Abbey, United Kingdom Jollyes is a large UK pet retailer. Jollyes has a growing portfolio of over 70 retail park superstores and concessions in garden centres across the UK. Jollyes focuses on providing its loyal and growing customer base with pet products and services that combine great quality and value. Jollyes has recently expanded its offering to customers to include grooming and veterinary services in store. Jollyes was founded in 1935 and is based in Waltham Abbey, United Kingdom. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-02-08 |
Optibrium
Cambridge, United Kingdom Optibrium is a drug discovery software provider to the pharmaceutical and biotech industries. Its StarDrop product is a complete platform of integrated software for small molecule design, optimisation and data analysis that enhances the speed and productivity of the drug discovery process. Optibrium’s Cerella product uses artificial intelligence to learn from complex drug discovery data to target high-potential chemical compounds. Optibrium was founded in 2009 and is based in Cambridge, United Kingdom. |
Buy | - |
